Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01861899 · ClinicalTrials.gov registry record
Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
A clinical trial, sponsored by Globus Medical.
- Completed
- Registry status
- 46
- Enrollment target
NCT01861899: Completed study, sponsored by Globus Medical.
NCT01861899 is a clinical trial that has completed, run by Globus Medical. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01861899 has completed, sponsored by Globus Medical.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The objective of this study is to gather clinical data on SI-LOK® for the treatment of sacroiliac joint dysfunction. The purpose of this prospective study is to evaluate clinical and radiographic outcomes, intra-operative parameters, patient satisfaction and work status following a procedure using SI-LOK® for treatment of sacroiliac joint dysfunction with a minimum of three screws.
Primary Outcome
Fusion Assessment Radiolucency
Interventions
- DEVICE SI-LOK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2013-05-02 |
| Est. Completion | 2019-04-11 |
What the finished NCT01861899 record still lists
NCT01861899 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SI-LOK is the first listed.
NCT01861899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01861899 about?
NCT01861899 is a clinical study titled "Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK". The objective of this study is to gather clinical data on SI-LOK® for the treatment of sacroiliac joint dysfunction. The purpose of this prospective study is to evaluate clinical and radiographic outcomes, intra-operative parameters, patient satisfaction and work status following a procedure using ...
What is the current status of trial NCT01861899?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2013-05-02. Estimated completion is 2019-04-11.
What interventions are being tested in trial NCT01861899?
The interventions under investigation include: SI-LOK (DEVICE).
Who is sponsoring clinical trial NCT01861899?
This trial is sponsored by Globus Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI